GT Biopharma, Inc.

Form D Filings

Industry Group
Biotechnology
Entity Type
Corporation
CIK
0000109657
Previous Names
GT Biopharma, Inc., OXIS INTERNATIONAL INC
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
3/7/2025 Equity, Option to Acquire, Security to be Acquired $1,280,358 $1,280,358 $1,280,358 $0 2/25/2025 3/7/2025 D 000010965725000002
7/23/2020 Debt, Other $3,190,000 $5,607,000 Indefinite Indefinite 4/20/2020 7/23/2020 D/A 000165495420007958
6/12/2020 Debt, Other $2,417,000 $2,417,000 Indefinite Indefinite 4/20/2020 6/11/2020 D 000165495420006561
8/17/2018 Equity $5,140,000 $5,140,000 $5,140,000 $0 8/2/2018 8/16/2018 D 000165495418009332
2/6/2018 Debt, Option to Acquire $7,055,000 $7,055,000 $7,055,000 $0 1/23/2018 2/6/2018 D 000165495418001133
9/14/2017 Equity, Debt $4,540,000 $4,540,000 $4,540,000 $0 8/31/2016 9/14/2017 D 000093979817000077
7/27/2015 Equity, Debt $500,000 $500,000 $1,500,000 $1,000,000 7/9/2015 7/24/2015 D 000093979815000050
3/16/2015 Equity, Debt $2,050,000 $2,050,000 $3,000,000 $950,000 2/20/2015 3/13/2015 D 000093979815000012
7/31/2014 Debt, Option to Acquire $1,425,000 $1,425,000 $1,425,000 $0 7/24/2014 7/31/2014 D 000125085314000096